Lb Pharmaceuticals (LBRX) Shares Issued (2026)

Lb Pharmaceuticals (LBRX) recorded quarterly Shares Issued of $100.0 million in Q1 2026.

Lb Pharmaceuticals (LBRX) Shares Issued (2026) Analysis & Trends

Lb Pharmaceuticals' Shares Issued history runs 1 years deep, the most recent figure standing at $100.0 million for Q1 2026.

In Q1 2026, Shares Issued changed N/A year-over-year to $100.0 million; the TTM figure through Mar 2026 stood at $100.0 million (changed N/A YoY), while the FY2025 annual figure was $247000.0, up 973.91% from the prior year.
Shares Issued was $100.0 million for Q1 2026 at Lb Pharmaceuticals.
In the past five years, Shares Issued ranged from a high of $100.0 million in Q1 2026 to a low of $100.0 million in Q1 2026.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Shares Issued (Qtr)
1	Alterity Therapeutics	925,601.88 Bn	925,601.85 Bn	-	-
2	Belite Bio	58,560.00 Bn	58,560.00 Bn	-	-
3	Quantum Biopharma	17,284.41 Bn	17,284.40 Bn	-	5.40 Mn
4	Legend Biotech	2,809.00 Bn	2,808.71 Bn	242.10 Mn	-
5	Evaxion A	1,334.43 Bn	1,334.42 Bn	-	-
6	Akari Therapeutics	1,312.27 Bn	1,312.26 Bn	-	-
7	Psyence Biomedical	212.16 Bn	212.16 Bn	-	-
8	Vertex Pharmaceuticals	114.83 Bn	107.58 Bn	2.59 Bn	27.00 Mn
9	Abivax	91.96 Bn	91.96 Bn	-	26,927.15
10	Lb Pharmaceuticals	843.30 Mn	843.30 Mn	-	100.00 Mn

Historic Data

Download Data

Date	Value
Mar 31, 2026	100.00 Mn
Mar 31, 2026	100.00 Mn